Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer. Dostarlimab...
37 KB (3,213 words) - 00:29, 30 September 2024
CSCC who are not candidates for curative surgery or curative radiation. Dostarlimab (Jemperli) – was developed by GlaxoSmithKline and was first approved...
35 KB (3,450 words) - 03:38, 30 September 2024
stage II or III rectal adenocarcinoma were administered single-agent dostarlimab, an anti–PD-1 monoclonal antibody, every three weeks for six months....
146 KB (15,930 words) - 20:53, 7 November 2024
inhibitorsTooltip Programmed cell death protein 1 Nivolumab Pembrolizumab Cemiplimab Dostarlimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand...
80 KB (7,412 words) - 02:30, 16 October 2024
inhibitorsTooltip Programmed cell death protein 1 Nivolumab Pembrolizumab Cemiplimab Dostarlimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand...
9 KB (603 words) - 00:28, 30 September 2024
inhibitorsTooltip Programmed cell death protein 1 Nivolumab Pembrolizumab Cemiplimab Dostarlimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand...
46 KB (4,813 words) - 05:06, 15 October 2024
inhibitorsTooltip Programmed cell death protein 1 Nivolumab Pembrolizumab Cemiplimab Dostarlimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand...
9 KB (460 words) - 00:28, 30 September 2024
for breast and ovarian cancer. TSR-042 TSR-022 Dostarlimab – In February 2023, the FDA approved dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) for adults...
5 KB (364 words) - 23:58, 12 September 2024
inhibitorsTooltip Programmed cell death protein 1 Nivolumab Pembrolizumab Cemiplimab Dostarlimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand...
13 KB (1,060 words) - 00:29, 30 September 2024
hormone replacement therapy after treatment for endometrial cancer. Dostarlimab has been approved by the FDA for therapy of endometrial cancer with specific...
105 KB (10,821 words) - 12:23, 31 July 2024